5 Big Drug Companies Face R&D Drought

5 Big Drug Companies Face R&D Drought
Five of the world’s biggest drug companies do not have any potential billion-dollar drugs in late-stage development, highlighting the industry’s current poor R&D productivity, according to a report released on Wednesday.

Biotechblog
Scroll to Top